Figures & data
Table 1. Baseline patient characteristics.
Figure 1. IMPT and VMAT re-planning frequencies for treatment-trajectories with and without re-planning. Decisions to re-plan were based on the weekly repeated 4DCTs only, i.e., without dose accumulation. Whole-course ICTV coverage was evaluated with dose accumulation on the average planning 4DCT.
![Figure 1. IMPT and VMAT re-planning frequencies for treatment-trajectories with and without re-planning. Decisions to re-plan were based on the weekly repeated 4DCTs only, i.e., without dose accumulation. Whole-course ICTV coverage was evaluated with dose accumulation on the average planning 4DCT.](/cms/asset/9e8b5899-7492-470b-8901-35a413445d70/ionc_a_1669818_f0001_c.jpg)
Figure 2. Dose volume histograms for heart and lungs contours with VMAT and IMPT (accumulated dose including re-planning).
![Figure 2. Dose volume histograms for heart and lungs contours with VMAT and IMPT (accumulated dose including re-planning).](/cms/asset/3400ec8f-75e3-42a5-b911-cacfaaa309f3/ionc_a_1669818_f0002_c.jpg)
Figure 3. Accumulated dose distributions with VMAT and IMPT and mean heart dose reductions with IMPT in a subgroup of patients with substantial cardiac sparing with IMPT.
![Figure 3. Accumulated dose distributions with VMAT and IMPT and mean heart dose reductions with IMPT in a subgroup of patients with substantial cardiac sparing with IMPT.](/cms/asset/f9ace734-3175-4166-b6b0-5c6119cc384d/ionc_a_1669818_f0003_c.jpg)
Table 2. Full re-planning trajectories ICTV D98 and OAR mean dose summed on av_p4DCT.